Literature DB >> 3050272

Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.

W E Huffer1.   

Abstract

The effects of PTH and vitamin D on bone are the result of their direct and indirect effects on the functional cells of bone remodeling units and their precursors. These effects are probably modified or controlled by growth factors, cytokines, and PGs generated locally by the process of bone remodeling. Bone remodeling includes resorptive and bone forming phases, each with a longitudinal and a radial component of progression in time and space. Longitudinal resorption is rapid, prolonged and is probably carried out by osteoclasts utilizing hydrogen ions and lysosomal enzymes to remove mineral and organic components of bone in a highly localized and directed fashion. Individual osteoclasts are probably long-lived cells with a nuclear and perhaps a cytoplasmic turnover rate of 8%/day, with replenishment coming from preosteoclasts in the reversal zone. Radial resorption is slower and shorter than longitudinal resorption. It is carried out by reversal phase monocytes whose exact relationship to osteoclasts is not clear. Activated collagenase diffusing from osteogenic cells in the reversal zone could also play a role. The longitudinal rate of bone formation is probably a measure of the rate of proliferation and differentiation of osteogenic cells at the site at which they were activated. The radial rate of bone formation is a measure of how rapidly osteoblasts synthesize and mineralize bone matrix once they reach the resorption surface. PTH and vitamin D have no direct effects on mature osteoclasts. They may have direct stimulatory effects on proliferation and differentiation of osteoclast precursors and their fusion with osteoclasts but this is not clear because the ontogeny of osteoclasts vis a vis monocytes and other phagocytic cells is still not clear. It is likely that their effects to increase osteoclast precursors involve interactions among lymphocytes, monocytes, and hematopoietic stem cells at a distance from bone remodeling units and are mediated by 1,25(OH)2 vitamin D3 induced synthesis of cytokines and colony-stimulating factors. Stimulatory effects of PTH, vitamin D, PGs, and cytokines on osteoclasts are mediated by as yet undefined factors produced by osteoblasts. Osteoblasts stimulated by PTH could also inhibit osteoclasts by synthesizing and releasing PGs. PTH and vitamin D have diverse and often contradictory effects on the functional activity of osteoblast-like cells in vitro that are difficult to interpret because the relationship of these cells to osteoblasts in vivo is not clear.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050272

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats.

Authors:  E Bonucci; P Ballanti; A Martelli; E Mereto; G Brambilla; P Bianco; L Bufalino
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

2.  A model for investigating the local action of bone-acting agents in vivo: effects of hPTH(1-34) on the secondary spongiosa in the rat.

Authors:  T Takano-Yamamoto; G A Rodan
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

3.  A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.

Authors:  N Yamamoto; V R Naraparaju
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

4.  Structural aspects of the reversal phase of alveolar bone remodelling.

Authors:  Y S Kang; J S Ko; S M Hwang
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

5.  Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling.

Authors:  R T Ingram; Y K Park; B L Clarke; L A Fitzpatrick
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

6.  Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans.

Authors:  H Langberg; D Skovgaard; L J Petersen; J Bulow; M Kjaer
Journal:  J Physiol       Date:  1999-11-15       Impact factor: 5.182

Review 7.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

Review 8.  Use of non-collagen markers in osteoporosis studies.

Authors:  M T Parviainen; A Pirskanen; A Mahonen; E M Alhava; P H Mäenpää
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

9.  Purified Pasteurella multocida protein toxin reduces acid phosphatase-positive osteoclasts in the ventral nasal concha of gnotobiotic pigs.

Authors:  M R Ackermann; D A Adams; L L Gerken; M J Beckman; R B Rimler
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

10.  Time series prediction of plasma hormone concentration. Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls.

Authors:  K Prank; S J Nowlan; H M Harms; M Kloppstech; G Brabant; R D Hesch; T J Sejnowski
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.